Dentists in Sabetha, KS Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Randall J Kirwan, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 819 Main St, Sabetha, KS 66534 Phone: 785-284-3368 |
Mr. Allan C Ross, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 502 S Washington Ave, Sabetha, KS 66534 Phone: 785-284-3010 Fax: 785-284-3136 |
 Dr. Elizabeth Tedman, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 112 N 9th St, Sabetha, KS 66534 Phone: 785-284-2323 Fax: 785-284-0075 |
Dr. Terry D Whitten, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1309 S Us Highway 75, Sabetha, KS 66534 Phone: 785-284-3911 Fax: 785-284-3911 |
Dr. Kyle Gilbert Stallbaumer, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 112 N 9th St, Sabetha, KS 66534 Phone: 785-284-2323 |
News Archive
Emerson Ecologics announces exclusive distribution of EcoNugenics' BreastDefend dietary supplement
Emerson Ecologics, LLC announces an exclusive distribution to healthcare practitioners of BreastDefend™, EcoNugenics' newest product. BreastDefend is a professional dietary supplement formulated specifically to promote and maintain breast cellular health. EcoNugenics chose to distribute this product solely through Emerson Ecologics for the initial product launch because of Emerson's 16,000 practitioner customer base, as well as their strong quality assurance program.
College of Physicians and Surgeons of Ontario releases recommendations to target opioid public health crisis
The College of Physicians and Surgeons of Ontario released a set of wide-ranging recommendations to target the opioid public health crisis. The College is responsible for regulating Ontario's physicians in the public interest.
HIV targets achieved by United Kingdom, says report
The Joint United Nations Programme on HIV/Aids (UNAids) target for 2020 is 90-90-90 which means 90 percent people with HIV would be diagnosed, 90 percent of those diagnosed would receive anti-HIV or anti-retroviral treatment and 90 percent of those treated with antiretroviral drugs would achieve suppression of their viral load so that they cannot transmit the infection to others.
NewCardio enters new line of credit with existing shareholders
NewCardio, Inc., a cardiac diagnostic technology provider, today announced that it has entered into a new line of credit with three of its existing shareholders, one of which is represented on the Board of Directors, to strengthen its financial position. This will allow the company further time to fully commercialize its lead solution, QTinno™.
Biosign grants 3,115,000 stock options at $0.92 per share
Biosign Technologies Inc. announced today the grant of an aggregate of 3,115,000 stock options pursuant to the Company's stock option plan. An aggregate of 1,115,000 of such options were granted effective June 16, 2011 to four directors of the Company.
› Verified 9 days ago